Comparison of Oral Iron Supplement Formulations for Normalization of Iron Status Following Roux-EN-y Gastric Bypass Surgery: a Randomized Trial
The evidence behind recommendations for treatment of iron deficiency (ID) following roux-en-y gastric bypass surgery (RYGB) lacks high quality studies.
Academic, United States
The objective of the study is to compare the effectiveness of oral iron supplementation using non-heme versus heme iron for treatment of iron deficiency in RYGB patients.
In a randomized, single-blind study, women post-RYGB and iron deficient received non-heme iron (FeSO4, 195 mg/day) or heme iron (heme-iron-polypeptide, HIP, 31.5 to 94.5 mg/day) for 8 weeks. Measures of iron status, including blood concentrations of ferritin, soluble transferrin receptor (sTfR), and hemoglobin, were assessed.
At baseline, the mean ± standard deviation for age, BMI, and years since surgery of the sample was 41.5 ± 6.8 years, 34.4 ± 5.9 kg/m2, and 6.9 ± 3.1 years, respectively; and there were no differences between FeSO4 (N = 6) or HIP (N = 8) groups. Compliance was greater than 94%. The study was stopped early due to statistical and clinical differences between groups. Values before and after FeSO4 supplementation, expressed as least square means (95% CI) were hemoglobin, 10.8 (9.8, 11.9) to 13.0 (11.9, 14.0) g/dL; sTfR, 2111 (1556, 2864) to 1270 (934, 1737) μg/L; ferritin, 4.9 (3.4, 7.2) to 15.5 (10.6, 22.6) μg/L; and sTfR:ferritin ratio, 542 (273, 1086) to 103 (51, 204); all p < 0.0001. With HIP supplementation, no change was observed in any of the iron status biomarkers (all p > 0.05).
In accordance with recommendations, oral supplementation using FeSO4, but not HIP, was efficacious for treatment of iron deficiency after RYGB.
KeywordsIron deficiency Iron supplementation Nutritional complications Bariatric surgery
Roux-en-y gastric bypass
Body mass index
Soluble transferrin receptor
Total iron binding capacity
Heme iron polypeptide
- 2.American-Society-for-Metabolic-and-Bariatric-Surgery. Internet: http://s3.amazonaws.com/publicASMBS/Resources/Fact-Sheets/Metabolic-Bariatric-Surgery-Fact-Sheet-ASMBS2012.pdf. Accessed 20 May 2013.
- 11.Gudzune KA, Huizinga MM, Chang HY, et al. Screening and diagnosis of micronutrient deficiencies before and after bariatric surgery. Obes Surg. 2013; doi:10.1007/s11695-013-0919-x.
- 12.van der Beek ES, Monpellier VM, Eland I, et al. Nutritional deficiencies in gastric bypass patients; incidence, time of occurrence and implications for post-operative surveillance. Obes Surg. 2014; doi:10.1007/s11695-014-1456-y.
- 14.Karefylakis C, Naslund I, Edholm D, et al. Prevalence of anemia and related deficiencies 10 years after gastric bypass-a retrospective study. Obes Surg. 2014; doi:10.1007/s11695-014-1500-y.
- 18.Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by american association of clinical endocrinologists, the obesity society, and american society for metabolic & bariatric surgery*. Obesity (Silver Spring). 2013;21(Suppl 1):S1–S27. doi:10.1002/oby.20461.CrossRefGoogle Scholar
- 19.Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring). 2009;17(Suppl 1):S1–70. doi:10.1038/oby.2009.28.Google Scholar
- 34.Iron W-RM. Edtion ed. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, editors. Modern nutrition in health and disease. Baltimore: Lippincott Williams & Wilkins; 2014. p. 176–88.Google Scholar
- 36.Anonymous. Internet: https://www.consumerlab.com/results/hometest.asp. Accessed 12 Sept 2016.
- 38.R-Core-Team. Internet: http://www.R-project.org/. Accessed 26 May 2015.